Alejandra Gámez

2.0k total citations
38 papers, 1.5k citations indexed

About

Alejandra Gámez is a scholar working on Molecular Biology, Clinical Biochemistry and Rheumatology. According to data from OpenAlex, Alejandra Gámez has authored 38 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Molecular Biology, 22 papers in Clinical Biochemistry and 10 papers in Rheumatology. Recurrent topics in Alejandra Gámez's work include Metabolism and Genetic Disorders (22 papers), Biochemical and Molecular Research (13 papers) and Glycosylation and Glycoproteins Research (11 papers). Alejandra Gámez is often cited by papers focused on Metabolism and Genetic Disorders (22 papers), Biochemical and Molecular Research (13 papers) and Glycosylation and Glycoproteins Research (11 papers). Alejandra Gámez collaborates with scholars based in Spain, United States and Canada. Alejandra Gámez's co-authors include Belén Pérez, Magdalena Ugarte, Lourdes R. Desviat, Raymond C. Stevens, Christineh N. Sarkissian, Charles R. Scriver, Ángel L. Pey, Heidi Erlandsen, Celia Pérez‐Cerdá and Paul Fitzpatrick and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and PLoS ONE.

In The Last Decade

Alejandra Gámez

38 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Alejandra Gámez Spain 23 1.1k 795 315 214 159 38 1.5k
Christineh N. Sarkissian Canada 17 744 0.7× 583 0.7× 201 0.6× 137 0.6× 124 0.8× 21 1.0k
B. Middleton United Kingdom 21 764 0.7× 516 0.6× 318 1.0× 25 0.1× 133 0.8× 61 1.3k
Clara Iannuzzi Italy 25 969 0.8× 236 0.3× 470 1.5× 51 0.2× 51 0.3× 50 1.8k
Luisa Raijman United States 19 716 0.6× 582 0.7× 294 0.9× 37 0.2× 391 2.5× 25 1.3k
Margaret L. Fonda United States 20 589 0.5× 171 0.2× 157 0.5× 92 0.4× 378 2.4× 43 1.1k
Takahiro Hatanaka United States 15 535 0.5× 286 0.4× 110 0.3× 27 0.1× 561 3.5× 23 1.1k
Giovanna Colombo United States 19 446 0.4× 130 0.2× 95 0.3× 45 0.2× 145 0.9× 37 913
Joanne Hullihen United States 17 1.2k 1.1× 154 0.2× 132 0.4× 13 0.1× 64 0.4× 22 1.6k
Gerty T. Cori United States 12 510 0.4× 169 0.2× 245 0.8× 514 2.4× 112 0.7× 14 1.1k
Mirosław Soszyński Poland 18 508 0.4× 49 0.1× 346 1.1× 29 0.1× 68 0.4× 55 1.2k

Countries citing papers authored by Alejandra Gámez

Since Specialization
Citations

This map shows the geographic impact of Alejandra Gámez's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alejandra Gámez with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alejandra Gámez more than expected).

Fields of papers citing papers by Alejandra Gámez

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alejandra Gámez. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alejandra Gámez. The network helps show where Alejandra Gámez may publish in the future.

Co-authorship network of co-authors of Alejandra Gámez

This figure shows the co-authorship network connecting the top 25 collaborators of Alejandra Gámez. A scholar is included among the top collaborators of Alejandra Gámez based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alejandra Gámez. Alejandra Gámez is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Serrano, Mercedes, Alejandra Gámez, Pedro Seoane, et al.. (2024). Transcriptomic analysis identifies dysregulated pathways and therapeutic targets in PMM2-CDG. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1870(5). 167163–167163. 3 indexed citations
2.
Gámez, Josep, Francesc Carmona, Carles Lorenzo‐Bosquet, et al.. (2024). Myasthenia gravis concurrent with Parkinson’s disease in a Spanish cohort. Causation or correlation?. Neurological Sciences. 45(7). 3183–3189. 3 indexed citations
3.
Yuste‐Checa, Patricia, Lourdes R. Desviat, Magdalena Ugarte, et al.. (2020). Proteostasis regulators as potential rescuers of PMM2 activity. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1866(7). 165777–165777. 14 indexed citations
4.
Navarrete, Rosa, Eva Richard, Magdalena Ugarte, et al.. (2018). Identification of 34 novel mutations in propionic acidemia: Functional characterization of missense variants and phenotype associations. Molecular Genetics and Metabolism. 125(3). 266–275. 16 indexed citations
5.
Yuste‐Checa, Patricia, Ana Vega, Cristina Martín-Higueras, et al.. (2017). DPAGT1-CDG: Functional analysis of disease-causing pathogenic mutations and role of endoplasmic reticulum stress. PLoS ONE. 12(6). e0179456–e0179456. 19 indexed citations
6.
Sarkissian, Christineh N., Alejandra Gámez, Patrick Scott, et al.. (2011). Chaperone-Like Therapy with Tetrahydrobiopterin in Clinical Trials for Phenylketonuria: Is Genotype a Predictor of Response?. JIMD Reports. 5. 59–70. 11 indexed citations
7.
Sarkissian, Christineh N., Tse Siang Kang, Alejandra Gámez, Charles R. Scriver, & Raymond C. Stevens. (2011). Evaluation of orally administered PEGylated phenylalanine ammonia lyase in mice for the treatment of Phenylketonuria. Molecular Genetics and Metabolism. 104(3). 249–254. 37 indexed citations
8.
Jorge‐Finnigan, Ana, Alejandra Gámez, Belén Pérez, Magdalena Ugarte, & Eva Richard. (2010). Different altered pattern expression of genes related to apoptosis in isolated methylmalonic aciduria cblB type and combined with homocystinuria cblC type. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1802(11). 959–967. 13 indexed citations
9.
Jorge‐Finnigan, Ana, Cristina Aguado, Rocío Sánchez-Alcudia, et al.. (2010). Functional and structural analysis of five mutations identified in methylmalonic aciduria cbIB type. Human Mutation. 31(9). 1033–1042. 22 indexed citations
10.
Kang, Tse Siang, et al.. (2009). Converting an injectable protein therapeutic into an oral form: Phenylalanine ammonia lyase for phenylketonuria. Molecular Genetics and Metabolism. 99(1). 4–9. 48 indexed citations
11.
Gámez, Alejandra, Christineh N. Sarkissian, Marianne G. Patch, et al.. (2005). Structure-based chemical modification strategy for enzyme replacement treatment of phenylketonuria. Molecular Genetics and Metabolism. 86(1-2). 134–140. 50 indexed citations
12.
Gámez, Alejandra, Christineh N. Sarkissian, Lin Wang, et al.. (2005). Development of Pegylated Forms of Recombinant Rhodosporidium toruloides Phenylalanine Ammonia-Lyase for the Treatment of Classical Phenylketonuria. Molecular Therapy. 11(6). 986–989. 42 indexed citations
13.
Erlandsen, Heidi, Sankar Surendran, Raymond C. Stevens, et al.. (2004). Trends in Enzyme Therapy for Phenylketonuria. Molecular Therapy. 10(2). 220–224. 51 indexed citations
14.
Pey, Ángel L., Belén Pérez, Lourdes R. Desviat, et al.. (2004). Mechanisms underlying responsiveness to tetrahydrobiopterin in mild phenylketonuria mutations. Human Mutation. 24(5). 388–399. 103 indexed citations
15.
Matalon, Reuben, Richard Koch, Kimberlee Michals‐Matalon, et al.. (2004). Biopterin responsive phenylalanine hydroxylase deficiency. Genetics in Medicine. 6(1). 27–32. 50 indexed citations
16.
Shen, Zhouxin, Eden P. Go, Alejandra Gámez, et al.. (2004). A Mass Spectrometry Plate Reader: Monitoring Enzyme Activity and Inhibition with a Desorption/Ionization on Silicon (DIOS) Platform. ChemBioChem. 5(7). 921–927. 48 indexed citations
17.
Erlandsen, Heidi, Ángel L. Pey, Alejandra Gámez, et al.. (2004). Correction of kinetic and stability defects by tetrahydrobiopterin in phenylketonuria patients with certain phenylalanine hydroxylase mutations. Proceedings of the National Academy of Sciences. 101(48). 16903–16908. 138 indexed citations
18.
Gámez, Alejandra, et al.. (2003). Toward PKU Enzyme Replacement Therapy: PEGylation with Activity Retention for Three Forms of Recombinant Phenylalanine Hydroxylase. Molecular Therapy. 9(1). 124–129. 38 indexed citations
19.
Pey, Ángel L., Lourdes R. Desviat, Alejandra Gámez, Magdalena Ugarte, & Belén Pérez. (2003). Phenylketonuria: Genotype-phenotype correlations based on expression analysis of structural and functional mutations inPAH. Human Mutation. 21(4). 370–378. 105 indexed citations
20.
Gámez, Alejandra, Belén Pérez, Magdalena Ugarte, & Lourdes R. Desviat. (2000). Expression Analysis of Phenylketonuria Mutations. Journal of Biological Chemistry. 275(38). 29737–29742. 74 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026